Trade

with

Navidea Biopharmaceuticals Inc
(Amex: NAVB)
AdChoices
1.36
-0.04
-2.86%
After Hours :
1.36
0.00
0.00%

Open

1.41

Previous Close

1.40

Volume (Avg)

267.72k (594.97k)

Day's Range

1.36-1.41

52Wk Range

1.11-2.26

Market Cap.

210.89M

Dividend Rate ( Yield )

-

Beta

0.53

Shares Outstanding

150.64M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 1.13M

    • Net Income

    • -42.70M

    • Market Cap.

    • 210.89M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -1,702.52

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.53

    • Forward P/E

    • -5.71

    • Price/Sales

    • 67.57

    • Price/Book Value

    • -8.60

    • Price/Cash flow

    • -5.22

      • EBITDA

      • -39.52M

      • Return on Capital %

      • -171.90

      • Return on Equity %

      • -

      • Return on Assets %

      • -171.90

      • Book Value/Share

      • -0.16

      • Shares Outstanding

      • 150.64M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 2.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 450.30

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -32.19

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 74.98

            • 82.75

            • Pre-Tax Margin

            • -1,702.52

            • 39.38

            • Net Profit Margin

            • -1,702.52

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 81.50

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -8,180.40

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 3.34

              • 2.92

              • Quick Ratio

              • 2.92

              • 2.35

              • Interest Coverage

              • -11.35

              • 38.02

              • Leverage Ratio

              • -

              • 2.21

              • Book Value/Share

              • -0.16

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -4.27

                • 217.39

                • P/E Ratio 5-Year High

                • -16.03

                • 634.30

                • P/E Ratio 5-Year Low

                • -2.78

                • 124.82

                • Price/Sales Ratio

                • 72.46

                • 9.52

                • Price/Book Value

                • -9.23

                • 8.61

                • Price/Cash Flow Ratio

                • -5.22

                • 50.51

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -

                    (-)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -171.90

                    (-257.00)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -

                    (-)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • 0.43

                  • 1.48

                  • Asset Turnover

                  • 0.10

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -38.44M
                  Operating Margin
                  -3,399.73
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -5.22
                  Ownership

                  Institutional Ownership

                  35.99%

                  Top 10 Institutions

                  30.94%

                  Mutual Fund Ownership

                  8.15%

                  Float

                  98.51%

                  5% / Insider Ownership

                  3.28%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • iShares Russell 2000 (AU)

                  •  

                    2,225,567

                  • -1.46

                  • 1.57

                  • Vanguard Total Stock Mkt Idx

                  •  

                    2,021,134

                  • 0.00

                  • 1.34

                  • Vanguard Extended Market Index Fund

                  •  

                    1,561,507

                  • 0.36

                  • 1.04

                  • iShares Russell 2000 Growth

                  •  

                    809,926

                  • 0.34

                  • 0.57

                  • CREF Stock

                  •  

                    492,703

                  • 5.12

                  • 0.33

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    444,645

                  • 0.00

                  • 0.30

                  • Bridgeway Ultra Small Company Market

                  •  

                    390,480

                  • 0.00

                  • 0.26

                  • iShares Micro-Cap

                  •  

                    357,043

                  • 0.00

                  • 0.25

                  • iShares Russell 2000 Value

                  •  

                    221,330

                  • 0.26

                  • 0.16

                  • Schwab Small Cap Index Fund®

                  •  

                    221,100

                  • 44.70

                  • 0.15

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Platinum Management (ny) Llc

                  •  

                    14,915,631

                  • +5.98%

                  • 9.90

                  • Susquehanna Financial Group, LLLP

                  •  

                    6,313,568

                  • -2.93%

                  • 4.19

                  • Commerzbank AG

                  •  

                    5,500,000

                  • 0.00%

                  • 3.65

                  • Nomura Holdings Inc

                  •  

                    4,533,559

                  • -0.14%

                  • 3.01

                  • Vanguard Group, Inc.

                  •  

                    4,217,943

                  • +3.47%

                  • 2.80

                  • BlackRock Fund Advisors

                  •  

                    3,688,518

                  • +9.37%

                  • 2.45

                  • Wellington Management Company, LLP

                  •  

                    3,007,052

                  • -1.50%

                  • 2.00

                  • State Street Corp

                  •  

                    1,844,058

                  • -0.58%

                  • 1.22

                  • Northern Trust Investments, N.A.

                  •  

                    1,397,224

                  • -7.98%

                  • 0.93

                  • Voya Investments, LLC

                  •  

                    1,200,000

                  • 0.00%

                  • 0.79

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Distressed

                  Style

                  Small Growth

                  Navidea Biopharmaceuticals Inc was incorporated in Ohio in 1983 and reincorporated in Delaware in 1988. It is a biopharmaceutical company engaged in the development and commercialization of precision diagnostics and radiopharmaceutic...moreal agent. Its products include Lymphoseek Injection is a novel, receptor-targeted, small-molecule radiopharmaceutical used in lymphatic mapping procedures that are performed to help evaluate patients with breast cancer and melanoma. Manocept platform is predicated on the ability to specifically target the CD206 mannose receptor expressed on macrophages. This flexible and versatile platform acts as an engine for the design of purpose-built molecules offering the potential to be utilized across a range of diagnostic modalities, including single photon emission computed tom...moreography, positron emission tomography, intra-operative and/or optical-fluorescence detection in a variety of disease states. NAV4694 is a Fluorine-18 radiolabeled PET imaging agent being developed as an aid in the diagnosis of patients with signs or symptoms of Alzheimer’s disease and mild cognitive impairment. NAV5001 is an Iodine-123 radiolabeled SPECT imaging agent being developed as an aid in the diagnosis of Parkinson’s disease and other movement disorders, with potential use as a diagnostic aid in dementia. NAV1800 is a radiolabeled monoclonal antibody being developed as a diagnostic aid for use during surgery to help surgeons locate occult or metastatic cancer, with a focus on colorectal cancer. It faces competition from medical product and biotechnology companies, as well as from universities and other non-profit research organizations in the field of cancer diagnostics and treatment. As a developer, manufacturer and marketer of medical products, the Company is subject to regulation by, among other governmental entities, FDA and the corresponding state, local and foreign regulatory bodies in jurisdictions in which its products are sold.lessless

                  Key People

                  Dr. Michael M. Goldberg,M.D.

                  Director/CEO

                  Gordon A. Troup

                  Chairman of the Board/Director

                  Brent L. Larson

                  CFO/Secretary/Executive VP/Treasurer

                  Perry A. Karsen

                  Director

                  Brendan A. Ford

                  Director

                  • Navidea Biopharmaceuticals Inc

                  • 5600 Blazer Parkway

                  • Dublin, OH 43017-7550

                  • USA.Map

                  • Phone: +1 614 793-7500

                  • Fax: +1 614 793-7522

                  • navidea.com

                  Incorporated

                  1983

                  Employees

                  65

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: